CME Group posts record third-quarter revenue as trading stays busy
CME Group reported third-quarter 2026 revenue of $1.7 billion, its highest for any third quarter. Net income was $1.0 billion, or $2.89 per share.

CME Financials · 1 analysis
CME reported $1.7B in revenue (+13.0% YoY), compared with a +10.9% median across covered Financials peers. 1 open-market insider purchase recorded; 6 insider sales recorded.
CME Group reported third-quarter 2026 revenue of $1.7 billion, its highest for any third quarter. Net income was $1.0 billion, or $2.89 per share.
CME GROUP INC.: 12 recorded developments from 2 official sources in 2026-10.
CME GROUP INC.: 7 recorded developments from 5 official sources in 2026-09.
Monthly records are drafted by AI from each month’s checked filings and official sources (in English, as extracted), with every line linked to its source; storylines group related developments across analyses using vector embeddings (Amazon Titan Text Embeddings V2). Provisional context, not investment advice.
From the 10-Q for the period ended September 30, 2026, filed October 23, 2026. SEC
| Latest | Earlier | Change | |
|---|---|---|---|
| Revenue quarter | $1.7B | $1.5B | +13.0% |
| Operating income quarter | $1.1B | $973M | +17.4% |
| Net income quarter | $1B | $908M | +14.2% |
| Diluted EPS quarter | $2.89 | $2.49 | +16.1% |
| Operating cash flow year to date | $3.3B | $3.1B | +4.8% |
| Cash and cash equivalents balance | $2.2B | $4.4B | -50.2% |
As the company tagged them in its filing (SEC XBRL). Quarter and year figures are compared with the same period a year earlier, balances with the previous balance sheet. Download CSV
Revenue by quarter, $B
How this company compares with 39 covered companies in Financials (median revenue change +10.9% YoY), from archived SEC XBRL filings.
| Company | Latest revenue | Revenue YoY | Operating margin |
|---|---|---|---|
| CME Group Inc. CME | $1.7B | +13.0% | 65.7% |
| Berkshire Hathaway Inc BRK-B | $74.3B | +16.6% | — |
| Jpmorgan Chase & Co. JPM | $50.2B | +8.1% | — |
| Visa Inc. V | $45.9B | +14.8% | 61.2% |
| Bank of America Corp BAC | $30B | +3.2% | — |
| Progressive Corp PGR | $23.2B | +3.0% | — |
| Wells Fargo & Company WFC | $21.9B | +2.0% | — |
Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.
Filings about how the company is run: auditor changes, restatements, leadership changes, late filings, delistings, Schedule 13D stakes and SEC comment letters, newest first.
| Date | Event | Filing |
|---|---|---|
| September 9, 2026 | Director or officer departure or appointment (8-K item 5.02) | 8-K |
As filed with the SEC, read by code. A comment letter is part of the SEC staff’s routine review and does not by itself mean a problem; item 5.02 covers appointments as well as departures; Form 25 may concern a bond or another class of securities.
| Date | Person | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|---|
| November 9, 2026 | Daniel G Kaye | Sale notice filed | 532 | $304.17 | $161,818 | SEC |
| November 2, 2026 | Julie Winkler | Sale notice filed | 10,079 | $305.15 | $3,075,607 | SEC |
| November 2, 2026 | Howard J Siegel | Sale notice filed | 2,000 | $303.00 | $606,000 | SEC |
| October 27, 2026 | Sunil Cutinho | Sale notice filed | 5,000 | $298.70 | $1,493,500 | SEC |
| October 22, 2026 | Martin J Gepsman | Sale notice filed | 400 | $302.50 | $121,000 | SEC |
| September 25, 2026 | William R Shepard | Purchase | 293 | $268.76 | $78,626 | SEC |
| September 16, 2026 | Jonathan Marcus | Planned sale 10b5-1 plan | 388 | — | $106,102 | SEC |
| September 14, 2026 | Elizabeth A Cook | Sale | 500 | $280.11 | $140,055 | SEC |
| September 14, 2026 | Elizabeth Anne Cook Trust | Planned sale | 500 | — | $140,053 | SEC |
| Fund | Shares | Value | Change in shares | Quarter |
|---|---|---|---|---|
| BlackRock | 30,149,084 | $7,898,457,117 | -1.4% | Q3 2026 |
| State Street | 16,228,031 | $4,251,419,561 | -0.7% | Q3 2026 |
| Geode Capital Management | 9,392,678 | $2,463,575,042 | +1.3% | Q3 2026 |
| Norges Bank (Norway's sovereign fund) | 4,820,646 | $1,064,543,256 | — | Q2 2026 |
| Wellington Management | 4,057,047 | $1,062,865,174 | +123.4% | Q3 2026 |
| Two Sigma Investments | 2,413,750 | $632,354,225 | -0.3% | Q3 2026 |
| Capital Research Global Investors | 1,923,170 | $503,832,077 | +61.1% | Q3 2026 |
| Fidelity (FMR) | 1,375,044 | $360,234,154 | +3.9% | Q3 2026 |
| D. E. Shaw & Co. | 1,167,354 | $305,823,401 | -11.8% | Q3 2026 |
| Citadel Advisors | 1,030,728 | $270,030,121 | -31.5% | Q3 2026 |
| Millennium Management | 494,017 | $129,422,574 | -58.7% | Q3 2026 |
| Renaissance Technologies | 474,609 | $124,338,066 | -30.2% | Q3 2026 |
| Soros Fund Management | 30,028 | $7,866,735 | 0.0% | Q3 2026 |
| T. Rowe Price | 3,107,487 | $814,100 | +48.8% | Q3 2026 |
| Baupost Group (Seth Klarman) | 685,435 | $179,570 | +10.7% | Q3 2026 |
From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.